Market Opportunity: 850K-950K OGTT tests annually in Germany
Target Segment: OB/GYN clinics (280-320 clinics, 112K-128K test potential)
Positioning: Premium, ready-to-drink, EU-certified glucose solution
Year 1 Goal: 143,000 units sales = €388K revenue, 63% gross margin
Current Competitors:
Merck: Powder form, dominant (40-50% share), €0.90-1.20/unit
ratiopharm: Generic powder, widespread (20-30% share), €0.70-1.00/unit
ACL Laboratories: Ready-to-drink competitor (5-10% share), €2.00-3.00/unit
Fragmented (20-30% share): Small local suppliers, various pricing
Market Barriers:
High incumbent loyalty (Merck = status quo)
Price sensitivity among independent labs
SYNLAB = critical gatekeeper (35+ locations in Germany)
GERO-DEX Advantage:
Only ready-to-drink with clinical evidence backing
EU certified + quality reputation
Superior patient experience (no powder mixing required)
Better accuracy (consistent formulation vs. powder variables)
Decision Maker: Clinic director / Lab manager
Pain Point: Patient satisfaction, test efficiency, accuracy
Value Prop: Reduce patient anxiety, faster results, premium positioning
Purchase: 200-2,000 units/month per clinic
Pricing: €2.80-3.50/unit (they sell to patients €4.50-8.00)
Lead Time: Monthly reordering
Decision Maker: Regional procurement manager
Pain Point: Volume reliability, cost per test, patient experience
Value Prop: Fast shipping from Austria, competitive wholesale, branded advantage
Purchase: 50,000-80,000 units/quarter (bulk)
Pricing: Negotiated € contract (€1.50-2.00/unit wholesale)
Lead Time: Standing order, monthly adjustments
Decision Maker: Lab director
Pain Point: Differentiation from competitors, patient retention
Value Prop: Premium offering, margin opportunity
Purchase: 100-500 units/month
Pricing: €2.50-3.00/unit (they mark up 20-40%)
Lead Time: As-needed ordering
Channel 1: Medical Journal Advertising
Target Publication: Gynäkologie Österreich, Frauenarzt (German OB/GYN journals)
Ad Placement: 1/2-page color ad (February-March issues)
Message: “GERO-DEX: Klinische Evidenz, bessere Patientenerfahrung”
Call-to-Action: “Kostenlose 100er Probe anfordern” (Free 100-unit sample)
Cost: €8,000 per publication
Expected Response: 50-100 clinic inquiries
Channel 2: Professional Conference Presence
Event: DGGG (German OB/GYN Society) Annual Congress (May 2026)
Booth: Premium exhibit booth (€6K cost)
Staffing: 2x sales reps + 1x clinical advisor
Activations:
Live demo stations (GERO-DEX vs. powder comparison)
Free samples (500 units prepped in booth cooler)
“Best Patient Experience” competition (clinics submit patient feedback)
Expected Result: 100-150 qualified leads, 20-30 SYNLAB introductions
Channel 3: Digital Marketing
LinkedIn Campaign: Targeted to lab directors + OB/GYN clinic managers in Germany
Budget: €3,000/month (ads + content creation)
Creative:
Case study: “Clinic X reduces OGTT processing time by 40%”
ROI calculator: “Switching to GERO-DEX increases patient volume by 15%”
Clinical evidence summary
Expected Result: 200-300 website visits, 30-50 demo requests
Channel 4: Direct Outreach
Method: Cold calls + personalized email to clinic directors (list purchased via German Medical Directory)
Message: “GERO-DEX sample + ROI analysis tailored to your clinic”
Outreach Budget: €2,000 (2 months dedicated sales rep)
Expected Result: 20-30 initial meetings, 5-10 trial orders
Channel 1: Free Trial Program
Approach: Offer 1,000-unit trial to any qualifying clinic (SYNLAB or independent)
Terms:
Free sample (1,000 units max)
Track usage + patient feedback for 1 month
Clinic pays for usage beyond first 1,000
Follow-up call to discuss results
Cost: €1,500 per trial (1,000 units @€1.50 cost + admin)
Expected: 30-50 trials, 40-60% conversion to ongoing relationship
Channel 2: Regional Sales Meetings
Frequency: Monthly regional meetings in Berlin, München, Frankfurt, Hamburg
Attendees:
GERO sales rep
Clinic directors + lab managers (invited via email + phone)
SYNLAB procurement contacts (separate meeting)
Agenda:
Product demo
Clinical evidence presentation
Pricing discussion
Trial enrollment
Expected Result: 15-20 attendees per meeting, 50% conversion to trial or order
Channel 3: SYNLAB Negotiation
Timeline: Month 2-3 (pre-conference discussion) → Month 3-4 (intensive negotiation)
Deliverables:
SYNLAB contract negotiation document
Volume commitment: 50K-80K units Y1 minimum
Pricing: €1.75/unit wholesale (target)
Training: SYNLAB staff on GERO-DEX positioning (2 hours webinar)
Co-marketing: Joint announcement to SYNLAB field
Expected Result: Signed contract by Month 4, first order Month 5
Channel 1: Case Studies & Testimonials
Approach: Document successful clinic deployments
Deliverables:
3-5 written case studies (clinical outcomes, patient satisfaction, ROI)
2-3 video testimonials (clinic director + patient)
Success metrics: “Clinic X increased OGTT volume 25% with GERO-DEX”
Distribution: LinkedIn, medical journals, direct sales materials
Cost: €5,000 (video production + writing)
Channel 2: Referral Program
Incentive: €50 credit per referring clinic for each new clinic they introduce
Mechanism: Referring clinic gets discount voucher to pass to new clinic
Expected Result: 10-20 new clinic relationships via referral (Month 8-12)
Channel 3: Expansion into SYNLAB Secondary Labs
Approach: Once SYNLAB primary contract signed, expand to their smaller/regional labs
Method: SYNLAB broadcast email + training + incentive (early adopter discount)
Expected Result: 20-30 additional SYNLAB lab orders
Channel 4: Retained Media + Ongoing Digital
Medical Journal: Quarterly advertorials (clinical results, customer success stories)
LinkedIn: Weekly content (market trends, clinical insights, patient testimonials)
Email Newsletter: Monthly to clinic database (product updates, compliance news, tips)
Cost: €4,000/month (ongoing)
Segment |
Price |
Volume |
Terms |
|---|---|---|---|
OB/GYN Clinics |
€2.80-3.50/unit |
200-2,000/mo |
Monthly invoicing, Net 30 |
SYNLAB Wholesale |
€1.50-2.00/unit |
50K-80K/year |
Quarterly invoicing, Net 60 |
Independent Labs |
€2.50-3.00/unit |
100-500/mo |
Monthly, Net 30 |
Offer 1: “First 100 Clinics”
Early adopter discount: €2.60/unit (vs €2.80 regular)
Valid April-June 2026
Expected: 80-100 clinics sign up
Offer 2: “Volume Commitment Bonus”
Commit to 1,000+ units/month for 6 months → 5% discount (€2.66/unit)
Expected: 20-30 clinics
Offer 3: “SYNLAB Partner Bundle”
Free 100-unit sample for SYNLAB labs that order 5,000 units
Expected: 30-40 SYNLAB labs trial
Dedicated Germany Sales Rep (Hire by Month 1)
Territory: All of Germany (divvy by region if volume justifies)
Responsibilities:
Clinic prospecting (30 new clinic outreach/month)
SYNLAB relationship management
Trial conversions
Account management (monthly clinic check-ins)
Compensation: €35K salary + €5K quarterly bonus (per 20K units sold)
Reports to: VP Sales
Clinical Advisor (Shared, 20% time)
Responsibilities:
Prepare clinical evidence documents
Attend clinic meetings for Q&A
Train clinic staff on GERO-DEX benefits
Collect patient feedback data
Channel |
Month 1-2 |
Month 3-6 |
Month 7-12 |
Annual Total |
|---|---|---|---|---|
Medical Journals |
€8,000 |
€4,000 |
€8,000 |
€20,000 |
Conference (DGGG) |
€6,000 |
- |
- |
€6,000 |
Digital/LinkedIn |
€6,000 |
€12,000 |
€12,000 |
€30,000 |
Sales Rep Salary |
€11,667 |
€35,000 |
€35,000 |
€81,667 |
Case Studies/Content |
€3,000 |
€2,000 |
€5,000 |
€10,000 |
Samples & Promo |
€5,000 |
€3,000 |
€2,000 |
€10,000 |
Travel & Events |
€4,000 |
€3,000 |
€3,000 |
€10,000 |
Miscellaneous |
€2,000 |
€2,000 |
€2,000 |
€6,000 |
TOTAL |
€45,667 |
€61,000 |
€67,000 |
€173,667 |
Blended Cost per Unit (Year 1, 143K units): €173,667 / 143,000 = €1.21/unit marketing cost
Metric |
Month 1-2 Target |
Month 3-6 Target |
Month 7-12 Target |
Full Year Target |
|---|---|---|---|---|
Clinic Inquiries |
30-50 |
50-100 |
30-50 |
200 |
Trial Orders |
5-10 |
15-25 |
10-15 |
60 |
Ongoing Clinic Relationships |
5 |
20-30 |
40-50 |
60 |
Units Sold |
8K-12K |
25K-35K |
40K-50K |
143K |
Revenue |
€22K-42K |
€68K-113K |
€112K-175K |
€388K |
Gross Margin % |
58% |
62% |
65% |
63% |
Clinic Retention Rate |
- |
70% |
80% |
80% |
Week 1 of Each Quarter: Sales + marketing team reviews actual vs. targets
Adjustments: Based on clinic feedback, competitive moves, SYNLAB status
Forecast: Update next quarter outlook and budget allocation
If ACL Laboratories Cuts Price to €1.80-2.00/unit:
Our response: Drop OB/GYN price to €2.40-2.60 (maintain €0.80 premium for quality)
Messaging: “Clinical evidence + consistent formulation = worth the premium”
Action: Increase case study distribution, highlight patient satisfaction data
If Merck Launches Ready-to-Drink Product:
Risk: Medium (Merck has distribution, but slower to innovate)
Our response: Accelerate SYNLAB contract + clinic relationships (lock in early adopters)
Messaging: “First mover advantage = we have the clinical data, the case studies, the market knowledge”
If SYNLAB Refuses Partnership:
Risk: High impact, low probability
Response: Accelerate direct clinic channel + seek alternative wholesalers (EUROFINS, etc.)
Adjust Year 1 target down to 80K units (still profitable)
Phase |
Month |
Key Milestones |
|---|---|---|
Awareness |
Apr-May |
Journal ads live, DGGG booth reserved, LinkedIn campaign start |
Engagement |
Jun-Aug |
30-50 trials underway, SYNLAB contract signed, sales rep hired |
Scale |
Sep-Dec |
Case studies published, referral program active, 60+ clinic relationships, 143K units YTD |
Document Version: 1.0 | Status: READY FOR EXECUTION
Lead Owner: VP Sales + Marketing Manager (Germany)
Budget Approved: ✅ €173,667 (included in COGS forecast, €1.21/unit absorbed)
Next Step: Hire dedicated Germany sales rep (March 2026)